Gene · 4744
Papers2,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peripherin: A proposed biomarker of traumatic axonal injury triggered by mechanical force. | Eur J Neurosci | 2023 | 37574217 | PubTator, text mining | PubMed |
| Electrical Stimulation of Human Mesenchymal Stem Cells on Conductive Substrates Promotes Neural Priming. | Macromol Biosci | 2023 | 37571815 | PubTator, text mining | PubMed |
| Fluid Biomarkers of Neuro-Glial Injury in Human Status Epilepticus: A Systematic Review. | Int J Mol Sci | 2023 | 37569895 | PubTator, text mining | PubMed |
| Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. | Int J Mol Sci | 2023 | 37569509 | PubTator, text mining | PubMed |
| Differential Responses of Retinal Neurons and Glia Revealed via Proteomic Analysis on Primary and Secondary Retinal Ganglion Cell Degeneration. | Int J Mol Sci | 2023 | 37569482 | PubTator, text mining | PubMed |
| Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. | J Clin Med | 2023 | 37568462 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias. | Mol Cell Proteomics | 2023 | 37557955 | PubTator, text mining | PubMed |
| Case report: Asp194Ala variant in MFN2 is associated with ALS-FTD in an Italian family. | Front Genet | 2023 | 37547466 | PubTator, text mining | PubMed |
| Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study. | Cell Mol Life Sci | 2023 | 37543540 | PubTator, text mining | PubMed |
| Robust phenotyping of highly multiplexed tissue imaging data using pixel-level clustering. | Nat Commun | 2023 | 37528072 | PubTator, text mining | PubMed |
| Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy. | Medicina (Kaunas) | 2023 | 37512056 | PubTator, text mining | PubMed |
| Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges. | Int J Mol Sci | 2023 | 37511382 | PubTator, text mining | PubMed |
| Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. | Res Sq | 2023 | 37503252 | PubTator, text mining | PubMed |
| Implications of Incomplete Immunostaining in Membranous Lupus Nephritis. | Kidney360 | 2023 | 37499070 | PubTator, text mining | PubMed |
| Neurofilament Expression as a Biomarker of Post-COVID-19 Sudden Sensorineural Hearing Loss. | Diseases | 2023 | 37489444 | PubTator, text mining | PubMed |
| Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months. | Crit Care | 2023 | 37481590 | PubTator, text mining | PubMed |
| Transcriptomes of human primary skin fibroblasts of healthy individuals reveal age-associated mRNAs and long noncoding RNAs. | Aging Cell | 2023 | 37462262 | PubTator, text mining | PubMed |
| Identifying Biomarkers of Spinal Muscular Atrophy for Further Development. | J Neuromuscul Dis | 2023 | 37458045 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4744/papers?page=11